Literature DB >> 32291752

Kosaki overgrowth syndrome: A novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.

Alison Foster1,2, Basile Chalot3,4,5, Thalia Antoniadi6, Elise Schaefer7, Rebecca Keelagher6, Gavin Ryan6, Quentin Thomas8, Christophe Philippe4,5, Ange-Line Bruel4,5, Arthur Sorlin3,4,5, Christel Thauvin-Robinet3,4,5, Marc Bardou9,10, Maxime Luu9,10, Veronique Quenardelle11, Valerie Wolff11,12, Jessica Woodley6, Pierre Vabres13, Derek Lim2, Rebecca Igbokwe2, Annie Joseph14, Harriet Walker15, Andrea Jester15, Jonathan Ellenbogen16, Diana Johnson17, Bethanie Rooke18, Celia Moss1,18, Trevor Cole2, Laurence Faivre3,5.   

Abstract

Heterozygous activating variants in platelet-derived growth factor, beta (PDGFRB) are associated with phenotypes including Kosaki overgrowth syndrome (KOGS), Penttinen syndrome and infantile myofibromatosis (IM). Here, we present three new cases of KOGS, including a patient with a novel de novo variant c.1477A > T p.(Ser493Cys), and the oldest known individual age 53 years. The KOGS phenotype includes characteristic facial features, tall stature, scoliosis, hyperelastic thin skin, lipodystrophy, variable intellectual and neurological deterioration, and abnormalities on brain imaging. Long-term outcome is unknown. Our cases confirm the phenotypic spectrum includes progressive flexion contractures, camptodactyly, widely spaced teeth, and constriction rings. We also propose novel occasional features including craniosynostosis, ocular pterygia, anterior chamber cleavage syndrome, early osteoporosis, increased pigmentation, recurrent haematomas, predisposition to cellulitis, nail dystrophy, carpal tunnel syndrome, recurrent hypoglycaemia in infancy, joint dislocation, and splenomegaly. Importantly, we report fusiform aneurysm of the basilar artery in two patients. Complications include thrombosis and stroke in the oldest reported patient and fatal rupture at the age of 21 in the patient with the novel variant. We conclude that cerebrovascular complications are part of the phenotypic spectrum of KOGS and KOGS-like disorders and suggest vascular imaging is indicated in these patients.
© 2020 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PDGFRB; KOGS; Kosaki overgrowth syndrome; fusiform aneurysm; long-term outcome; vascular

Mesh:

Substances:

Year:  2020        PMID: 32291752     DOI: 10.1111/cge.13752

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  PDGF receptor mutations in human diseases.

Authors:  Emilie Guérit; Florence Arts; Guillaume Dachy; Boutaina Boulouadnine; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

2.  Skeletal stem cell fate defects caused by Pdgfrb activating mutation.

Authors:  Hae Ryong Kwon; Jang H Kim; John P Woods; Lorin E Olson
Journal:  Development       Date:  2021-12-02       Impact factor: 6.868

3.  Kosaki Overgrowth Syndrome: Report of a Family with a Novel PDGFRB Variant.

Authors:  Hatice Mutlu Albayrak; Alistair D Calder
Journal:  Mol Syndromol       Date:  2021-09-29

Review 4.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

5.  Somatic Mosaicism of a PDGFRB Activating Variant in Aneurysms of the Intracranial, Coronary, Aortic, and Radial Artery Vascular Beds.

Authors:  Carolina A Parada; Fatima M El-Ghazali; Daphne Toglia; Jacob Ruzevick; Malia McAvoy; Samuel Emerson; Yigit Karasozen; Tina Busald; Ahmad A Nazem; Shaun M Suranowitz; Sherene Shalhub; Desiree A Marshall; Luis F Gonzalez-Cuyar; Michael O Dorschner; Manuel Ferreira
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

6.  Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.

Authors:  Simone Hettmer; Guillaume Dachy; Guido Seitz; Abbas Agaimy; Catriona Duncan; Marjolijn Jongmans; Steffen Hirsch; Iris Kventsel; Uwe Kordes; Ronald R de Krijger; Markus Metzler; Orli Michaeli; Karolina Nemes; Anna Poluha; Tim Ripperger; Alexandra Russo; Stephanie Smetsers; Monika Sparber-Sauer; Eveline Stutz; Franck Bourdeaut; Christian P Kratz; Jean-Baptiste Demoulin
Journal:  Fam Cancer       Date:  2020-09-05       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.